10x Genomics (TXG) Assets Average (2019 - 2025)
Historic Assets Average for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to $1.0 billion.
- 10x Genomics' Assets Average rose 1143.57% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 1143.57%. This contributed to the annual value of $980.0 million for FY2025, which is 404.62% up from last year.
- Per 10x Genomics' latest filing, its Assets Average stood at $1.0 billion for Q4 2025, which was up 1143.57% from $1.0 billion recorded in Q3 2025.
- 10x Genomics' 5-year Assets Average high stood at $1.0 billion for Q4 2025, and its period low was $911.0 million during Q1 2025.
- In the last 5 years, 10x Genomics' Assets Average had a median value of $976.6 million in 2021 and averaged $974.7 million.
- Per our database at Business Quant, 10x Genomics' Assets Average skyrocketed by 6188.69% in 2021 and then plummeted by 758.46% in 2024.
- Quarter analysis of 5 years shows 10x Genomics' Assets Average stood at $1.0 billion in 2021, then increased by 0.79% to $1.0 billion in 2022, then dropped by 5.51% to $956.8 million in 2023, then decreased by 2.99% to $928.2 million in 2024, then rose by 11.44% to $1.0 billion in 2025.
- Its Assets Average was $1.0 billion in Q4 2025, compared to $1.0 billion in Q3 2025 and $941.7 million in Q2 2025.